title: Systemic lupus erythematosus presenting earlier as retinal vaso-occlusion.
abstract: Retinal vascular lesions are the most common ophthalmologic manifestation of systemic lupus erythematosus (SLE), occurring in 3% to 29% of cases, generally late in the disease. More rare is the severe vaso-occlusive disease, often termed "retinal vasculitis", which includes central retinal artery occlusion, multifocal arteriolar occlusions, extensive capillary nonperfusion and central venous occlusion. Patients with SLE and raised serum concentrations of anticardiolipin antibodies (ACA) have a higher risk of developing occlusive ocular vascular disease. We report a case in which retinal involvement was an earlier manifestation of SLE in a patient without ACA.
authors.affiliation: Department of Internal Medicine, Catholic University of Daegu, School of Medicine, Korea.
authors.forename: Y H
authors.initials: YH
authors.lastname: Song
authors.forename: C G
authors.initials: CG
authors.lastname: Kim
authors.forename: S D
authors.initials: SD
authors.lastname: Kim
authors.forename: Y Y
authors.initials: YY
authors.lastname: Kim
authors.forename: J Y
authors.initials: JY
authors.lastname: Choe
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000792:Angiography; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy; D009887:Ophthalmoscopy; D012170:Retinal Vein Occlusion / Q000175:diagnosis* / Q000188:drug therapy; D016896:Treatment Outcome; D014792:Visual Acuity
chemical_list: D000305:Adrenal Cortex Hormones